| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.924 | 0.005 | 0.995 | DNA directed DNA polymerase inhibitor | 0.577 0.061 DBMET00895 0.969 0.004 DBMET00898 0.995 0.003 DBMET00899 | DBMET00899 | |
| 0.903 | 0.002 | 0.986 | DNA synthesis inhibitor | 0.719 0.004 DBMET00895 0.959 0.001 DBMET00898 0.986 0.001 DBMET00899 | DBMET00899 | |
| 0.888 | 0.002 | 0.926 | DNA directed RNA polymerase inhibitor | 0.636 0.004 DBMET00895 0.892 0.002 DBMET00898 0.926 0.002 DBMET00899 | DBMET00899 | |
| 0.814 | 0.001 | 0.965 | RNA-directed DNA polymerase inhibitor | 0.652 0.003 DBMET00895 0.919 0.001 DBMET00898 0.965 0.001 DBMET00899 | DBMET00899 | |
| 0.799 | 0 | 0.799 | Transcription factor NF kappa B stimulant | 0.715 0.001 DBMET00895 0.791 0.001 DBMET00898 0.784 0.001 DBMET00899 | ||
| 0.627 | 0.003 | 0.78 | HIV-1 reverse transcriptase inhibitor | 0.398 0.004 DBMET00895 0.696 0.003 DBMET00898 0.78 0.002 DBMET00899 | DBMET00899 | |
| 0.506 | 0.003 | 0.516 | Peptidyltransferase inhibitor | 0.516 0.003 DBMET00895 0.435 0.005 DBMET00898 0.407 0.006 DBMET00899 | DBMET00895 | |
| 0.378 | 0.007 | 0.699 | DNA polymerase I inhibitor | 0.355 0.008 DBMET00895 0.537 0.003 DBMET00898 0.699 0.001 DBMET00899 | DBMET00899 | |
| 0.357 | 0.018 | 0.357 | Hepatoprotectant | 0.244 0.045 DBMET00895 0.263 0.04 DBMET00898 0.259 0.041 DBMET00899 | ||
| 0.312 | 0.003 | 0.527 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.293 0.004 DBMET00895 0.441 0.002 DBMET00898 0.527 0.001 DBMET00899 | DBMET00899 | |
| 0.274 | 0.005 | 0.636 | Carbamoyl phosphate synthetase inhibitor | 0.271 0.005 DBMET00895 0.561 0.002 DBMET00898 0.636 0.001 DBMET00899 | DBMET00899 | |
| 0.274 | 0.023 | 0.274 | Lipid peroxidase inhibitor | 0.121 0.092 DBMET00895 0.147 0.07 DBMET00898 | ||
| 0.247 | 0.007 | 0.472 | Mucolytic | 0.243 0.007 DBMET00895 0.271 0.005 DBMET00898 0.472 0.003 DBMET00899 | DBMET00899 | |
| 0.238 | 0.008 | 0.538 | Phosphofructokinase-1 inhibitor | 0.231 0.009 DBMET00895 0.399 0.003 DBMET00898 0.538 0.002 DBMET00899 | DBMET00899 | |
| 0.234 | 0.015 | 0.53 | Expectorant | 0.227 0.016 DBMET00895 0.306 0.008 DBMET00898 0.53 0.003 DBMET00899 | DBMET00899 | |
| 0.188 | 0.008 | 0.519 | Argininosuccinate synthase inhibitor | 0.166 0.01 DBMET00895 0.385 0.003 DBMET00898 0.519 0.002 DBMET00899 | DBMET00899 | |
| 0.188 | 0.011 | 0.704 | Glutamate dehydrogenase inhibitor | 0.18 0.012 DBMET00895 0.509 0.003 DBMET00898 0.704 0.002 DBMET00899 | DBMET00899 | |
| 0.296 | 0.138 | 0.296 | Antibacterial | 0.234 0.193 DBMET00895 0.233 0.194 DBMET00898 | ||
| 0.15 | 0.012 | 0.316 | Antimetabolite | 0.17 0.011 DBMET00895 0.252 0.007 DBMET00898 0.316 0.005 DBMET00899 | DBMET00899 | |
| 0.15 | 0.02 | 0.15 | Acetylcholine M3 receptor agonist | 0.094 0.049 DBMET00898 | ||
| 0.154 | 0.027 | 0.448 | UDP-glucose 4-epimerase inhibitor | 0.137 0.034 DBMET00895 0.362 0.007 DBMET00898 0.448 0.004 DBMET00899 | DBMET00899 | |
| 0.153 | 0.029 | 0.185 | DNA repair enzyme inhibitor | 0.134 0.049 DBMET00895 0.185 0.012 DBMET00898 0.115 0.084 DBMET00899 | DBMET00898 | |
| 0.133 | 0.011 | 0.56 | Ornithine carbamoyltransferase inhibitor | 0.12 0.013 DBMET00895 0.376 0.003 DBMET00898 0.56 0.002 DBMET00899 | DBMET00899 | |
| 0.196 | 0.081 | 0.196 | DNA methylase inhibitor | 0.142 0.124 DBMET00895 0.184 0.09 DBMET00898 | ||
| 0.17 | 0.062 | 0.453 | Cytidine deaminase inhibitor | 0.206 0.045 DBMET00895 0.276 0.023 DBMET00898 0.453 0.007 DBMET00899 | DBMET00899 | |
| 0.11 | 0.035 | 0.264 | NADH dehydrogenase inhibitor | 0.109 0.035 DBMET00895 0.209 0.01 DBMET00898 0.264 0.007 DBMET00899 | DBMET00899 | |
| 0.078 | 0.007 | 0.623 | Fumarate hydratase inhibitor | 0.067 0.009 DBMET00895 0.359 0.002 DBMET00898 0.623 0.001 DBMET00899 | DBMET00899 | |
| 0.112 | 0.051 | 0.361 | Adenylate kinase inhibitor | 0.106 0.058 DBMET00895 0.275 0.008 DBMET00898 0.361 0.004 DBMET00899 | DBMET00899 | |
| 0.086 | 0.025 | 0.205 | Ribonucleotide reductase inhibitor | 0.076 0.028 DBMET00895 0.148 0.012 DBMET00898 0.205 0.007 DBMET00899 | DBMET00899 | |
| 0.083 | 0.024 | 0.134 | Ribonucleoside-diphosphate reductase inhibitor | 0.073 0.027 DBMET00895 0.133 0.014 DBMET00898 0.134 0.014 DBMET00899 | DBMET00899 | |
| 0.143 | 0.087 | 0.409 | Hexokinase inhibitor | 0.132 0.101 DBMET00895 0.289 0.012 DBMET00898 0.409 0.004 DBMET00899 | DBMET00899 | |
| 0.122 | 0.066 | 0.417 | Adenylate cyclase inhibitor | 0.093 0.091 DBMET00895 0.286 0.015 DBMET00898 0.417 0.007 DBMET00899 | DBMET00899 | |
| 0.064 | 0.012 | 0.137 | Thymidine kinase inhibitor | 0.056 0.015 DBMET00895 0.097 0.006 DBMET00898 0.137 0.004 DBMET00899 | DBMET00899 | |
| 0.048 | 0.015 | 0.211 | Phosphoglycerate kinase inhibitor | 0.043 0.018 DBMET00895 0.125 0.005 DBMET00898 0.211 0.003 DBMET00899 | DBMET00899 | |
| 0.043 | 0.011 | 0.106 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.046 0.01 DBMET00895 0.086 0.004 DBMET00898 0.106 0.002 DBMET00899 | DBMET00899 | |
| 0.169 | 0.139 | 0.344 | Immunostimulant | 0.172 0.138 DBMET00895 0.344 0.066 DBMET00898 0.313 0.075 DBMET00899 | DBMET00898 | |
| 0.157 | 0.134 | 0.305 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.26 0.038 DBMET00898 0.305 0.022 DBMET00899 | DBMET00899 | |
| 0.086 | 0.065 | 0.451 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.066 DBMET00895 0.235 0.009 DBMET00898 0.451 0.003 DBMET00899 | DBMET00899 | |
| 0.03 | 0.011 | 0.03 | Thymidine phosphorylase inhibitor | 0.026 0.017 DBMET00895 0.03 0.011 DBMET00898 | ||
| 0.137 | 0.119 | 0.137 | DNA methyltransferase I inhibitor | |||
| 0.058 | 0.043 | 0.184 | Biliverdin reductase inhibitor | 0.184 0.007 DBMET00898 0.184 0.007 DBMET00899 | DBMET00899 | |
| 0.043 | 0.031 | 0.043 | HIV-1 protease inhibitor | |||
| 0.024 | 0.013 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.023 0.014 DBMET00895 | ||
| 0.184 | 0.176 | 0.184 | MAP kinase kinase 3 inhibitor | |||
| 0.012 | 0.005 | 0.029 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET00895 0.021 0.002 DBMET00898 0.029 0.001 DBMET00899 | DBMET00899 | |
| 0.016 | 0.01 | 0.242 | Purinergic P2 agonist | 0.015 0.01 DBMET00895 0.066 0.002 DBMET00898 0.242 0.001 DBMET00899 | DBMET00899 | |
| 0.016 | 0.01 | 0.242 | Purinergic receptor agonist | 0.015 0.01 DBMET00895 0.066 0.002 DBMET00898 0.242 0.001 DBMET00899 | DBMET00899 | |
| 0.042 | 0.038 | 0.042 | Adenosine deaminase inhibitor | |||
| 0.012 | 0.009 | 0.219 | Purinergic P2Y agonist | 0.012 0.01 DBMET00895 0.057 0.002 DBMET00898 0.219 0.001 DBMET00899 | DBMET00899 | |
| 0.021 | 0.021 | 0.021 | Adenosine A1 receptor agonist | 0.021 0.02 DBMET00898 | DBMET00898 | |
| 0.002 | 0.004 | 0.008 | Purinergic P2Y6 agonist | 0.005 0.001 DBMET00898 0.008 0.001 DBMET00899 | DBMET00899 | |
| 0.003 | 0.006 | 0.069 | Purinergic P2Y4 agonist | 0.009 0.002 DBMET00898 0.069 0.001 DBMET00899 | DBMET00899 | |
| 0.029 | 0.032 | 0.189 | Purinergic P2Y2 antagonist | 0.114 0.004 DBMET00898 0.189 0.002 DBMET00899 | DBMET00899 | |
| 0.019 | 0.027 | 0.208 | Purinergic P2X agonist | 0.089 0.004 DBMET00898 0.208 0.002 DBMET00899 | DBMET00899 | |
| 0.044 | 0.052 | 0.16 | Antiviral (Hepatitis D) | 0.085 0.007 DBMET00898 0.16 0.003 DBMET00899 | DBMET00899 | |
| 0.012 | 0.021 | 0.034 | Purinergic P2Y1 agonist | 0.024 0.005 DBMET00898 0.034 0.003 DBMET00899 | DBMET00899 | |
| 0.037 | 0.047 | 0.082 | Thymidylate synthase inhibitor | 0.082 0.007 DBMET00898 | DBMET00898 | |
| 0.043 | 0.053 | 0.144 | Acyl-CoA dehydrogenase inhibitor | 0.11 0.014 DBMET00898 0.144 0.01 DBMET00899 | DBMET00899 | |
| 0.015 | 0.028 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 DBMET00898 0.023 0.005 DBMET00899 | DBMET00899 | |
| 0.072 | 0.098 | 0.179 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.179 0.019 DBMET00898 0.178 0.02 DBMET00899 | DBMET00898 | |
| 0.016 | 0.041 | 0.028 | Uridine phosphorylase inhibitor | 0.028 0.02 DBMET00898 | DBMET00898 | |
| 0.045 | 0.081 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.039 DBMET00898 | DBMET00898 | |
| 0.026 | 0.072 | 0.073 | Guanylate cyclase inhibitor | 0.059 0.013 DBMET00898 0.073 0.004 DBMET00899 | DBMET00899 | |
| 0.009 | 0.057 | 0.023 | Adenosine kinase inhibitor | 0.023 0.014 DBMET00899 | DBMET00899 | |
| 0.096 | 0.148 | 0.126 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET00895 | DBMET00895 | |
| 0.007 | 0.068 | 0.14 | Purinergic P2T antagonist | 0.025 0.014 DBMET00898 0.14 0.004 DBMET00899 | DBMET00899 | |
| 0.012 | 0.083 | 0.113 | HCV NS5B polymerase inhibitor | 0.033 0.019 DBMET00898 0.113 0.005 DBMET00899 | DBMET00899 | |
| 0.007 | 0.092 | 0.046 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.034 0.007 DBMET00898 0.046 0.005 DBMET00899 | DBMET00899 | |
| 0.059 | 0.176 | 0.102 | Alkylator | 0.1 0.089 DBMET00895 0.102 0.086 DBMET00898 | DBMET00898 | |
| 0.033 | 0.157 | 0.143 | Purinergic P2X1 antagonist | 0.091 0.019 DBMET00898 0.143 0.008 DBMET00899 | DBMET00899 | |
| 0.022 | 0.159 | 0.262 | Purinergic P2X2 antagonist | 0.19 0.005 DBMET00898 0.262 0.003 DBMET00899 | DBMET00899 | |
| 0.007 | 0.148 | 0.101 | Purinergic P2Y12 antagonist | 0.029 0.013 DBMET00898 0.101 0.004 DBMET00899 | DBMET00899 | |
| 0.11 | 0.252 | 0.179 | DNA damaging | 0.179 0.135 DBMET00895 | DBMET00895 | |
| 0.014 | 0.174 | 0.081 | RNA-directed RNA polymerase inhibitor | 0.081 0.007 DBMET00899 | DBMET00899 | |
| 0.001 | 0.178 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DBMET00898 0.008 0.006 DBMET00899 | DBMET00898 | |
| 0.008 | 0.223 | 0.047 | Geranyltranstransferase inhibitor | 0.047 0.026 DBMET00899 | DBMET00899 | |
| 0.009 | 0.227 | 0.044 | Phosphorylase inhibitor | 0.044 0.034 DBMET00899 | DBMET00899 | |
| 0.007 | 0.273 | 0.131 | Purinergic P2Y antagonist | 0.06 0.019 DBMET00898 0.131 0.006 DBMET00899 | DBMET00899 | |
| 0.099 | 0.396 | 0.173 | Heat shock protein 70 antagonist | 0.173 0.016 DBMET00899 | DBMET00899 | |
| 0.052 | 0.352 | 0.102 | Folate antagonist | 0.102 0.06 DBMET00898 | DBMET00898 | |
| 0.004 | 0.324 | 0.052 | Purinergic P2Y1 antagonist | 0.039 0.004 DBMET00898 0.052 0.004 DBMET00899 | DBMET00899 | |
| 0.038 | 0.385 | 0.116 | Aldehyde dehydrogenase inhibitor | 0.116 0.076 DBMET00899 | DBMET00899 | |
| 0.028 | 0.412 | 0.088 | Phosphodiesterase I inhibitor | 0.088 0.062 DBMET00899 | DBMET00899 | |
| 0.047 | 0.486 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 DBMET00898 | DBMET00898 | |
| 0.018 | 0.534 | 0.193 | Pyruvate kinase inhibitor | 0.193 0.085 DBMET00899 | DBMET00899 | |
| 0.005 | 0.626 | 0.037 | Growth factor receptor-bound protein 2 antagonist | 0.037 0.02 DBMET00898 0.034 0.026 DBMET00899 | DBMET00898 | |
| 0.041 | 0.777 | 0.178 | Sphingosine 1-phosphate receptor 2 agonist | 0.178 0.015 DBMET00898 | DBMET00898 | |
| 0.008 | 0.756 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.011 DBMET00898 0.025 0.024 DBMET00899 | DBMET00898 | |
| 0.004 | 0.844 | 0.162 | Purinergic P2 antagonist | 0.162 0.009 DBMET00899 | DBMET00899 | |
| 0.004 | 0.932 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.035 DBMET00898 | DBMET00898 | |
| 0.002 | 0.959 | 0.067 | Sphingosine 1-phosphate receptor 3 agonist | 0.067 0.01 DBMET00898 | DBMET00898 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |